GENOTYPIC AND PHENOTYPIC VARIATION IN THE ENV GENE OF AVIAN RETROVIRUSES NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


GENOTYPIC AND PHENOTYPIC VARIATION IN THE ENV GENE OF AVIAN RETROVIRUSES

Diss Abstr Int [B]; 50(3):937 1989. Unique Identifier : AIDSLINE ICDB/90659530
Hill CB; Univ. of North Carolina at Chapel Hill


Abstract: Avian retroviruses have been classified into five distinct subgroups based on host range (specific receptor recognition), antigenicity (response to specific neutralizing antibodies), and interference (masking of the receptor by the viral glycoprotein). Using recombinant viruses made from cloned DNA isolates, the role of the gp85-coding domain of env in both receptor recognition and recognition by subgroup-specific neutralizing antibodies was defined. The gp85-coding domains from four different virus isolates (subgroups A, B, D, and E) were sequenced and compared to the known sequence of a subgroup C isolate. Four variable regions in the nucleotide sequence (and the predicted amino acid sequence) were defined that correlate with subgroup specificity. An extreme conservation of secondary structure was predicted for the different subgroup viruses by computer analysis of secondary structure. From sequence comparisons of viruses of the same subgroup, seven hypervariable domains were identified along the gp85-coding domain. The heterogeneity in the sequence did not appear to influence receptor binding by the individual viruses; however, the heterogeneity was shown to be distinguishable by neutralizing antibodies. If the neutralizing antibodies act to block receptor interaction, then the occurrence of the hypervariable domains within the variable domains supports the role of the variable domains in defining the receptor binding domain. The sequence of a host range variant, a subgroup D virus, was analyzed to address the role of sequence variability in gp85 that enables the virus to penetrate mammalian cells. The host range of recombinant subgroup B and subgroup D viruses was analyzed in a susceptible mammalian cell line. The extended host range phenotype of the subgroup D virus appears to be caused by multiple domains along the primary gp85-coding sequence. The results of the recombinant virus study suggest that the ability of the subgroup D virus to penetrate mammalian cells involves a destabilization of the glycoprotein complex perhaps enabling the viral envelope to nonspecifically fuse with the cell membrane. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD89-14427)
Keywords: Animal Base Sequence Birds/*MICROBIOLOGY DNA, Viral/GENETICS Gene Products, env/*GENETICS *Genes, Viral Genotype Phenotype Recombination, Genetic Retroviridae/CLASSIFICATION/*GENETICS Retroviridae Proteins/*GENETICS Variation (Genetics) THESISKWDanimalbasesequencebirds/KWDmicrobiologydna,viral/geneticsgeneproducts,env/KWDgeneticsKWDgenes,viralgenotypephenotyperecombination,geneticretroviridae/classification/KWDgeneticsretroviridaeproteins/KWDgeneticsvariation(genetics)thesis
900530
M9051027

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .